跳至主要内容
临床试验/ISRCTN12559751
ISRCTN12559751已完成4 期

An interventional, double-blind randomized parallel-group, phase IV study for the assessment of a tailored Opioid therapy and osteoarthritic chronic pain bioMarkers, to improve Arthoprosthesis patients rehabilitation (OpMarkArt)

ISAL Foundation0 个研究点目标入组 60 人开始时间: 2017年5月23日最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patients who started opioid analgesics category and will undergo total hip arthroplasty for osteoarthritis or aseptic necrosis of the femoral head
  • 2. Patients who started NonSteroidal Anti-Inflammatory Drugs (NSAIDs) and will undergo total hip arthroplasty (THA) for osteoarthritis or aseptic necrosis of the femoral head
  • 3. Males and female adults (from 18 years old)

排除标准

  • 1. Unstable neurological pathologies
  • 2. Uncompensated diabetes
  • 3. Previous abdominal surgery with dynamic ileum risk
  • 4. Viral infective pathologies
  • 5. Patients unable to fill the informed consent form
  • 6. Patients needing post-surgery mechanical ventilation
  • 7. Patients attending a secondary surgery
  • 8. Retreated patients

研究者

发起方
ISAL Foundation

相似试验